[1] |
Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong.
Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
|
[2] |
Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei.
Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
|
[3] |
Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei.
Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950.
|
[4] |
Zhang Hongtai, Ren Yixuan, Hu peilei, Wang Nenhan, Li Jie, Tian Lili, Zhao Yanfeng, Chen Shuangshuang, Li Chuanyou.
Comparison of microbiota diversity in the sputum of pulmonary tuberculosis patients with rifampicin resistance or sensitivity
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 625-633.
|
[5] |
Ge Fei, Zhu Hui, Cheng Kai, Lu Yu, Xu Jian.
Study on the determination of isoniazid and its metabolites concentration in plasma by high-performance liquid chromatography-mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 549-556.
|
[6] |
Cheng Mengli, Jiang Guanglu, Huo Fengmin, Xue Yi, Yu Xia.
Evaluation of in vitro activity of fusidic acid against mycobacteria
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 461-466.
|
[7] |
Pei Shaojun, Ou Xichao.
Interpretation of the World Health Organization’s Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance (2nd Edition)
[J]. Chinese Journal of Antituberculosis, 2024, 46(3): 260-266.
|
[8] |
Gulina Badeerhan, Liu Nianqiang, Yipaer Aihaiti, Wang Le, Wang Senlu, Zulikatiayi Abudula, Wang Mingzhe, Zhang Jing, Wang Xinqi, Bi Hongbo.
The effect of GeneXpert MTB/RIF detection technology in tuberculosis prevention and control program in Xinjiang
[J]. Chinese Journal of Antituberculosis, 2024, 46(2): 173-177.
|
[9] |
Ruan Yunzhou, Su Wei, Zhang Hui, Zhao Yanlin.
Historical evolution and prospect of rifampicin-resistant tuberculosis prevention and control in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1166-1170.
|
[10] |
Li Jing, Jiang Qi, Jiang Yuan, Shen Xin.
Evaluation of performance of PCR fluorescent probe method for detecting Mycobacterium tuberculosis complex and rifampicin resistance
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1250-1258.
|
[11] |
Liu Mei, Wu Xia, Gu Xu, Li Nana, Zhang Wanmin, Zhang Xiaoke, Lan Yuanbo.
Evaluation of the performance of InnowaveDX MTB/RIF in detecting Mycobacterium tuberculosis complex and rifampicin resistance
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 70-74.
|
[12] |
Ren Ruyan, Xue Yi, Liang Qian, Huang Hairong.
The mechanisms identification of the susceptibility discrepancy to isoniazid among clinical isolates of Mycobacterium kansasii
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 728-733.
|
[13] |
Song Yuanyuan, Xia Hui, Zhao Yanlin.
Development process of setting of critical concentrations for phenotypic drug susceptibility testing of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(7): 631-638.
|
[14] |
Zhu Yumei, Xia Zihan, Li Jinli, He Huishan, Wang Feng.
Application value of multicolor melting curve analysis in detection of pre-extensive drug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 406-411.
|
[15] |
Lyu Tong, Yang Yunbin, Pan Ying, Cheng Yuyu, Li Zichao, Xu Lin.
Analysis of economic burden and influencing factors of rifampin-resistant pulmonary tuberculosis in Yunnan Province
[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1031-1037.
|